Related Experiment Video
Updated: May 5, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma
1Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, NY, USA.
Abstract:
We identified a discrete number of microRNAs differentially expressed in benign or malignant mesothelial tissues. We focused on mir-145 whose levels were significantly downregulated in malignant mesothelial tissues and malignant pleural mesothelioma (MPM) cell lines as compared to benign tissues (pleura, peritoneum or cysts). We show that promoter hyper-methylation caused very low levels in MPM cell lines and specimens. Treatment of MPM cell lines with mir-145 agonists negatively modulated some protumorigenic properties of MPM cells, such as clonogenicity, cell migration and resistance to pemetrexed treatment. The main effector mechanism of the clonogenic death induced by mir-145 was that of accelerated senescence. We found that mir-145 targeted OCT4 via specific binding to its 3'-UTR. Increased intracellular levels of mir-145 decreased the levels of OCT4 and its target gene ZEB1, thereby counteracting the increase of OCT4 induced by pemetrexed treatment which is known to favor the development of chemoresistant cells. In line with this, reintroduction of OCT4 into mimic-145 treated cells counteracted the effects on clonogenicity and replicative senescence. This further supports the relevance of the mir-145-OCT4 interaction for the survival of MPM cells. The potential use of mir-145 expression levels to classify benign vs malignant mesothelial tissues and the differences between pemetrexed-induced senescence and that induced by the re-expression of mir-145 are discussed.
Insights
MicroRNA-145 (miR-145) is downregulated in malignant pleural mesothelioma (MPM) due to hyper-methylation. Restoring miR-145 levels inhibits MPM cell growth and chemoresistance by targeting OCT4.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Mesothelioma is a rare cancer with limited treatment options.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- Identifying novel biomarkers and therapeutic targets for mesothelioma is essential.
Purpose of the Study:
- To investigate the role of differentially expressed miRNAs in benign versus malignant mesothelial tissues.
- To elucidate the function and mechanism of miR-145 in malignant pleural mesothelioma (MPM).
- To explore the therapeutic potential of miR-145 in MPM.
Main Methods:
- Differential expression analysis of miRNAs in mesothelial tissues and cell lines.
- Assessment of miR-145 levels and its correlation with promoter hyper-methylation in MPM.
- In vitro studies using miR-145 agonists to evaluate effects on MPM cell properties (clonogenicity, migration, chemoresistance).
- Investigation of the miR-145 targeting mechanism involving OCT4 and ZEB1.
Main Results:
- miR-145 was significantly downregulated in malignant mesothelial tissues and MPM cell lines.
- Promoter hyper-methylation was identified as a cause for low miR-145 levels in MPM.
- miR-145 restoration reduced MPM cell clonogenicity, migration, and pemetrexed resistance.
- miR-145 induced accelerated senescence in MPM cells by targeting OCT4 and its downstream gene ZEB1.
- The miR-145-OCT4 interaction is critical for MPM cell survival.
Conclusions:
- miR-145 acts as a tumor suppressor in MPM, with its downregulation mediated by hyper-methylation.
- Restoring miR-145 levels holds therapeutic potential for MPM by inhibiting cell proliferation and overcoming chemoresistance.
- miR-145 levels may serve as a biomarker for distinguishing benign from malignant mesothelial tissues.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Pleural Disorders: Types and Brief Description
Induced Pluripotent Stem Cells
Somatic...

